{"id":"W2151507583","doi":"10.1634/theoncologist.12-4-426","title":"Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors","year":2007,"lang":"en","type":"review","venue":"The Oncologist","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":418,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Sorafenib; Medicine; Clinical trial; Pharmacokinetics; Refractory (planetary science); Pharmacology; Oncology; Drug; Toxicity; Safety profile; Phases of clinical research; Internal medicine; Medical physics; Adverse effect; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002528225,0.0003788288,0.002687295,0.00008980659,0.00003630333,0.000004059964,0.0003572225,0.0002220103,0.00001672947],"category_scores_gemma":[0.0008430054,0.0002237392,0.0002925249,0.0001736305,0.0003485554,0.000005403218,0.0002122409,0.0002769179,0.000001033106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004359872,"about_ca_system_score_gemma":0.0003932847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001022978,"about_ca_topic_score_gemma":0.000007816653,"domain_scores_codex":[0.9969282,0.0009414047,0.00125477,0.0004084771,0.0002099864,0.0002571342],"domain_scores_gemma":[0.9968787,0.0003263841,0.002046304,0.0005431658,0.0001365758,0.00006879766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002108481,0.0008143817,0.00003217136,0.03626572,0.0001599065,0.000019974,0.000009222145,6.872654e-7,0.001041626,0.000005128835,0.0003713441,0.9591714],"study_design_scores_gemma":[0.006354828,0.01096288,0.0004801076,0.04862639,0.001515669,0.00003559519,0.00001116645,0.000001256548,0.004239493,0.000004528715,0.9271909,0.0005771985],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01443642,0.982094,0.0000513755,0.00001695019,0.0001241218,0.002377074,0.0003499078,0.000005730272,0.0005444643],"genre_scores_gemma":[0.0152949,0.983953,0.0001913688,0.00005513,0.0000918709,0.00006934455,0.0002504617,0.00003608641,0.00005783149],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9585941,"threshold_uncertainty_score":0.912382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07306418962376841,"score_gpt":0.4061245175451803,"score_spread":0.3330603279214119,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}